2025-12-31
ENA first public
ERC000011
ENA-CHECKLIST
Research Institute for Reproductive Medicine and Genetic Diseases,  The Affiliated Wuxi Maternity and Child Health Care Hospital of Nanjing Medical University
INSDC center name
public
INSDC status
ERS22821324
SRA accession
E-MTAB-14741:si_LINC_1
Submitter Id
ArrayExpress
broker name
OVCAR3
cell_line
epithelial cell
cell_type
not collected
collection date
human
common name
Protocols: OVCAR3 cells were purchased from the Institute of Biochemistry and Cell Biology of the Chinese Academy of Sciences (Shanghai, China). OVCAR3 cells were supplemented with 20% fetal bovine serum. Cells were harvested 48 hours post-transfection for subsequent experiments, including transfection efficiency and functional assays. Total RNA was extracted from cells and tissues using the RNA isolator Total RNA Extraction Reagent (Vazyme, Nanjing, China) according to the manufacturer's instructions. RNA was then reverse-transcribed into cDNA using the HiScript III RT SuperMix qPCR kit (Vazyme).
description
adult
developmental stage
ovarian cancer
disease
wild type genotype
genotype
not collected
geographic location (country and/or sea)
not applicable
isolate
Homo sapiens
organism
Homo sapiens
organism
ovary
organism part
Homo sapiens
scientific_name
si_LINC_1
title